论文信息 - Nivolumab (Nivo) maintenance (maint) in high-risk (HR) acute myeloid leukemia (AML) patients. - 字舞流文

Nivolumab (Nivo) maintenance (maint) in high-risk (HR) acute myeloid leukemia (AML) patients.

M. Konopleva | H. Kantarjian | J. Cortes | T. Kadia | F. Ravandi | E. Jabbour | N. Daver | Y. Alvarado | M. Ohanian | A. Ghorab